FIRE1
Founded Year
2016Stage
Series C - II | AliveTotal Raised
$90.63MLast Raised
$25M | 7 days agoAbout FIRE1
FIRE1 (Foundry Innovation & Research 1) provides healthcare and medical device solutions. The company focuses on developing novel remote monitoring devices. The company helps to improve patient quality of life and outcomes for those suffering from chronic diseases and reduce the burden of heart failure. FIRE1 was founded in 2016 and is based in Dublin11, Ireland.
FIRE1's Product Videos
Compete with FIRE1?
Ensure that your company and products are accurately represented on our platform.
FIRE1's Products & Differentiators
norm
Heart failure patient management system
Expert Collections containing FIRE1
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
FIRE1 is included in 5 Expert Collections, including Medical Devices.
Medical Devices
8,633 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health Monitoring & Diagnostics
3,465 items
Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance
Digital Health
12,697 items
Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)
Telehealth
2,856 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Health IT
8,881 items
Latest FIRE1 News
Mar 15, 2023
DUBLIN--(BUSINESS WIRE)--FIRE1 has raised $25 million to revolutionize heart failure home monitoring.
FIRE1 Frequently Asked Questions (FAQ)
When was FIRE1 founded?
FIRE1 was founded in 2016.
Where is FIRE1's headquarters?
FIRE1's headquarters is located at Old Finglas Road, Dublin 11.
What is FIRE1's latest funding round?
FIRE1's latest funding round is Series C - II.
How much did FIRE1 raise?
FIRE1 raised a total of $90.63M.
Who are the investors of FIRE1?
Investors of FIRE1 include Lightstone Ventures, New Enterprise Associates, Medtronic, Seventure Partners, Ireland Strategic Investment Fund and 7 more.
Who are FIRE1's competitors?
Competitors of FIRE1 include Endotronix and 2 more.
What products does FIRE1 offer?
FIRE1's products include norm.
Who are FIRE1's customers?
Customers of FIRE1 include and undefined.
Compare FIRE1 to Competitors
Acorai develops a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM) to help reduce hospitalizations and readmissions. The Acorai Heart Monitor can monitor intracardiac pressures non-invasively through a machine learning analysis of pressure dynamics in acoustics, vibratory, and waveform data. The company was founded in 2019 and is based in Helsingborg, Sweden.
Butterfly Network operates within diagnostic and therapeutic imaging with devices, deep learning, and the cloud. Butterfly Network operates at the intersection of engineering and medicine by bringing together computer science, physics, mechanical engineering, electrical engineering, and medicine. The company was founded in 2011 and is based in Guilford, Connecticut.
Pattern Computer develops a proprietary, end-to-end system for generating new hypotheses and insights from data to help transform research or businesses. The company's hypothesis-generating engine is prompting new ways of assessing and solving difficult and entrenched problems in medical research.
Xeltis provides a clinical-stage medical device. It offers restorative devices including implantable small-diameter blood vessels for hemodialysis vascular access and for coronary artery bypass graft (CABG) surgery and pulmonary heart valves. The company was founded in 2006 and is based in Eindhoven, Netherlands.
iAssay is a provider of point of care diagnostics solutions. The company provides an open platform for wirelessly connected point of care (POC) diagnostics. The device aggregates test, patient, and wearables data and pushes all data into the cloud. The aim is to eliminate test result delays, delayed diagnosis, sample handling and transportation costs. It also aim to improve patient outcomes and save the healthcare system money.
Provigate specializes in developing home-based blood glucose measurement sensors and devices and a monitoring app for people who are worried about diabetes and those who have diabetes. Its mission is to trigger healthier behavior changes by providing home-use glucose monitoring systems. It is based in Tokyo, Japan.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.